1. Home
  2. VSTS vs HTFL Comparison

VSTS vs HTFL Comparison

Compare VSTS & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vestis Corporation

VSTS

Vestis Corporation

N/A

Current Price

$12.12

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Logo Heartflow Inc.

HTFL

Heartflow Inc.

N/A

Current Price

$50.12

Market Cap

2.2B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
VSTS
HTFL
Founded
1936
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.2B
IPO Year
2023
2025

Fundamental Metrics

Financial Performance
Metric
VSTS
HTFL
Price
$12.12
$50.12
Analyst Decision
Sell
Strong Buy
Analyst Count
4
5
Target Price
$5.88
$38.20
AVG Volume (30 Days)
1.3M
2.1M
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
82.37
EPS
0.05
N/A
Revenue
$2,734,839,000.00
$176,034,000.00
Revenue This Year
N/A
$27.66
Revenue Next Year
$1.67
$23.55
P/E Ratio
$242.60
N/A
Revenue Growth
N/A
39.92
52 Week Low
$3.98
$20.13
52 Week High
$16.90
$51.19

Technical Indicators

Market Signals
Indicator
VSTS
HTFL
Relative Strength Index (RSI) 29.88 80.94
Support Level $12.17 $22.96
Resistance Level $12.60 $51.19
Average True Range (ATR) 0.38 2.69
MACD -0.07 0.36
Stochastic Oscillator 10.00 95.28

Price Performance

Historical Comparison
VSTS
HTFL

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

About HTFL Heartflow Inc.

HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.

Share on Social Networks: